Latest news with #fiscal2025
Globe and Mail
4 days ago
- Business
- Globe and Mail
Automatic Data Processing to Report Q4 Earnings: What's in Store?
Automatic Data Processing, Inc. ADP is scheduled to release fourth-quarter fiscal 2025 results on July 30, before market open. ADP has a decent earnings surprise history, surpassing the Zacks Consensus Estimate in the trailing four quarters, with an average surprise of 3.5%. Automatic Data Processing, Inc. Price and EPS Surprise Automatic Data Processing, Inc. price-eps-surprise | Automatic Data Processing, Inc. Quote Automatic Data Processing's Q4 Expectations The Zacks Consensus Estimate for the top line is $5.1 billion, hinting at a 5.9% year-over-year increase. We expect gains across segments to have supported revenue growth. Our estimation for fourth-quarter fiscal 2025 revenues from Employer Service is $3.4 billion, suggesting growth of 5.7% from the year-ago quarter's actual. We expect business bookings to have fueled this segment's growth. We anticipate revenues of Professional Employer Organization ('PEO') services to be $1.6 billion, indicating 5.6% year-over-year growth. The factors likely to have driven this segment are higher wages and strong retention. Our estimate for Interest on Funds held for clients is $287.9 million, implying a 4% rise from the year-ago quarter's reported figure. Stronger average client funds balance growth is anticipated to have benefited this segment. Our estimate for Average Paid PEO Worksite Employees for the quarter is 762. Changes in Pay per control are anticipated to be 0.1% for the to-be-reported quarter. The consensus estimate for earnings per share is set at $2.22, indicating a 6.2% year-over-year increase. Strong top-line growth, along with disciplined cost control, is expected to have aided the bottom line. What Our Model Says About ADP Our proven model does not conclusively predict an earnings beat for Automatic Data Processing this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that is not the case here. You can uncover the best stocks before they are reported with our Earnings ESP Filter. ADP has an Earnings ESP of -0.53% and a Zacks Rank of 3 at present. You can see the complete list of today's Zacks #1 Rank stocks here. Stocks to Consider Here are a few stocks from the broader Computer And Technology sector, which, according to our model, have the right combination of elements to beat on earnings this season. Seagate Technology STX: The Zacks Consensus Estimate for the company's fiscal fourth-quarter 2025 revenues is pegged at $2.4 billion, indicating a year-over-year increase of 27.5%. For earnings, the consensus mark is pegged at $2.46 per share, suggesting a more than 100% surge from that reported in the year-ago quarter. The company beat the Zacks Consensus Estimate in the past four quarters, with an average surprise of 15.7%. STX currently has an Earnings ESP of +2.34% and a Zacks Rank #2. The company is scheduled to declare fourth-quarter fiscal 2025 results on July 29. Apple AAPL: The Zacks Consensus Estimate for the company's third-quarter fiscal 2025 revenues is pegged at $88.9 billion, suggesting year-over-year growth of 3.7%. For earnings, the consensus mark is pegged at $1.42 per share, implying a 1.43% rise from the year-ago quarter's actual. The company beat the Zacks Consensus Estimate in the past four quarters, with an average surprise of 4.7%. AAPL has an Earnings ESP of +3.52% and a Zacks Rank #3 at present. The company is scheduled to declare third-quarter fiscal 2025 results on July 31. #1 Semiconductor Stock to Buy (Not NVDA) The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow. One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be. See This Stock Now for Free >> Apple Inc. (AAPL): Free Stock Analysis Report
Globe and Mail
22-07-2025
- Business
- Globe and Mail
NIKE's Inventory Cleanup Continues: Is it Too Little, Too Late?
NIKE Inc. 's NKE ongoing efforts to streamline inventory and reset the marketplace remain central to its turnaround strategy. However, concerns linger about whether these moves are coming too late to reverse the broader slowdown in growth. In fourth-quarter fiscal 2025, revenues dropped nearly 12% year over year, while inventory remained flat, signaling that while progress has been made, excess stock still weighs heavily on the business. The company has aggressively discounted aging products like Air Force 1, Dunk and AJ1 through value channels, but its digital business continues to struggle with weak traffic and ongoing promotions. To regain control, NIKE is pursuing a phased inventory reset. It expects to reach a 'healthy and clean' inventory position by the end of the first half of fiscal 2026. That means more discounting in the near term and continued pressure on digital traffic, which was down 26% in the fiscal fourth quarter. In key regions like North America and EMEA, the inventory quality is improving, with better sell-through rates and growing full-price sales. However, markets like Greater China still lag, requiring deeper discounting, supply cuts and retail concept overhauls. While NIKE maintains that its inventory cleanup is on track, some analysts are skeptical. Ongoing reliance on markdowns and value channels risks brand dilution and weakens long-term consumer perception. With a $1 billion tariff headwind looming, any misstep in inventory or pricing could further delay the path to profitable growth. Success now hinges on the company's ability to clear aging stock while reigniting demand for new, full-price products. NKE's Competition in the Global Arena adidas AG ADDYY and lululemon athletica inc. LULU are the key companies competing with NIKE in the global market. adidas has made notable progress in normalizing its inventory after being weighed down by excess stock, particularly from discontinued Yeezy products. In its recent earnings reports, the company highlighted double-digit declines in inventory levels, noting that cleaner inventory helped improve sell-through rates and reduce discounting pressure. adidas has become more disciplined in supply planning, enabling it to focus on core franchises with improved full-price sales. lululemon has taken a more cautious approach to inventory management, though pressures are rising. The company reported a 23% increase in dollar inventory and 16% in units in the first quarter of fiscal 2025, mainly due to tariffs and FX, and not overstocking. While traffic in the United States remains soft, lululemon is confident in its inventory quality and has only modestly raised markdown expectations for the second half. NKE's Price Performance, Valuation & Estimates Shares of NIKE have lost 2.2% year to date compared with the industry 's decline of 6.6%. Image Source: Zacks Investment Research From a valuation standpoint, NKE trades at a forward price-to-earnings ratio of 41.17X compared with the industry's average of 29.33X. The Zacks Consensus Estimate for NKE's fiscal 2025 earnings implies a year-over-year plunge of 22.7%, while that for fiscal 2026 indicates growth of 55%. The company's EPS estimate for fiscal 2025 and fiscal 2026 has moved down in the past 30 days Image Source: Zacks Investment Research NIKE stock currently carries a Zacks Rank #4 (Sell). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%. Free: See Our Top Stock And 4 Runners Up Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report NIKE, Inc. (NKE): Free Stock Analysis Report lululemon athletica inc. (LULU): Free Stock Analysis Report Adidas AG (ADDYY): Free Stock Analysis Report
Globe and Mail
15-07-2025
- Business
- Globe and Mail
United Natural Foods to Host Business Update Call on July 16, 2025
United Natural Foods, Inc. (NYSE: UNFI) will host a call with the investment community at 8:30 a.m. ET on Wednesday July 16, 2025 to provide an update on the previously disclosed cyber incident and the Company's outlook for fiscal 2025. To access the conference call, please dial (800) 715-9871 (U.S. toll-free) and reference conference ID number 5462932. An audio webcast of the conference call, and materials that will be referenced during the call, will be available via the Investors section of the Company's website An online archive of the webcast will be available for 120 days. About United Natural Foods, Inc. UNFI is North America's premier grocery wholesaler delivering the widest variety of fresh, branded, and owned brand products to more than 30,000 locations throughout North America, including natural product superstores, independent retailers, conventional supermarket chains, ecommerce providers, and food service customers. UNFI also provides a broad range of value-added services and segmented marketing expertise, including proprietary technology, data, market insights, and shelf management to help customers and suppliers build their businesses and brands. As the largest full-service grocery partner in North America, UNFI is committed to building a food system that is better for all and is uniquely positioned to deliver great food, more choices, and fresh thinking to customers. To learn more about how UNFI is delivering value for its stakeholders, visit
Yahoo
15-07-2025
- Business
- Yahoo
Albertsons Companies Announces Common Stock Dividend
BOISE, Idaho, July 15, 2025--(BUSINESS WIRE)--Albertsons Companies, Inc. (NYSE: ACI) (the "Company") today announced its Board of Directors has declared a cash dividend for the second quarter of fiscal 2025 of $0.15 per share of common stock. The cash dividend is payable on August 8, 2025, to stockholders of record as of the close of business on July 25, 2025. About Albertsons Companies Albertsons Companies is a leading food and drug retailer in the United States. As of June 14, 2025, the Company operated 2,264 retail stores with 1,725 in-store pharmacies, 408 associated fuel centers, 22 dedicated distribution centers and 19 manufacturing facilities. The Company operates stores across 35 states and the District of Columbia under 22 well-known banners including Albertsons, Safeway, Vons, Jewel-Osco, Shaw's, ACME, Tom Thumb, Randalls, United Supermarkets, Pavilions, Star Market, Haggen, Carrs, Kings Food Markets and Balducci's Food Lovers Market. The Company is committed to helping people across the country live better lives by making a meaningful difference, neighborhood by neighborhood. In 2024, along with the Albertsons Companies Foundation, the Company contributed more than $435 million in food and financial support, including more than $40 million through our Nourishing Neighbors Program to ensure those living in our communities and those impacted by disasters have enough to eat. Important Notice Regarding Forward-Looking Statements This press release contains certain forward-looking statements. Statements that are not historical facts, including statements regarding the Company's expectations, perspectives and projected financial performance, are forward-looking statements. The words "expect," "believe," "estimate," "intend," "plan" and similar expressions, when related to the Company and its subsidiaries, indicate forward-looking statements. The forward-looking statements are based on the Company's current expectations and involve risks and uncertainties. The Company cautions that the risks and uncertainties could cause actual results to differ materially from those expressed or implied in the forward-looking statements. The Company also cautions that undue reliance should not be placed on any of the forward-looking statements, which speak only as of the date of this release. The Company undertakes no responsibility to update any of these forward-looking statements to reflect events or circumstances after the date of this report or to reflect actual outcomes. Certain potential factors that could affect our business and financial results and cause actual results to differ materially from those expressed or implied in any forward-looking statements are described in the "Risk Factors" section or other sections in our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the "SEC") on April 21, 2025, and in reports subsequently filed with the SEC and available at the SEC's website at View source version on Contacts For Investor Relations, contact investor-relations@ For Media Relations, contact media@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
12-07-2025
- Business
- Associated Press
Jack Nathan Health Announces Its Q4 and Year End Fiscal 2025 Financial Results
TORONTO--(BUSINESS WIRE)--Jul 11, 2025-- Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ('Jack Nathan Health', 'JNH' or the 'Company') announced today its audited consolidated annual financial results for the fourth quarter of fiscal 2025, and fiscal year ended January 31, 2025. Jack Nathan Health's financial statements are prepared in accordance with International Financial Reporting Standards ('IFRS'). Disclosure Regarding Filing Timing As previously disclosed in a press release issued on June 9, 2025, the Company was unable to file its annual financial statements, MD&A, and related CEO and CFO certifications for the fiscal year ended January 31, 2025, by the prescribed filing deadline of May 31, 2025. The delay was due to operational restructuring, resource realignment, and transition impacts following the divestiture of its Canadian primary care operations and the winding down of Mexico operations. The Company is pleased to confirm that it has now completed the filings within the 90-day permitted period, and all required documents are available on SEDAR+. Management Commentary Mike Marchelletta, Chief Executive Officer, commented: 'Fiscal 2025 was a pivotal year of transition for Jack Nathan Health. We successfully completed the divestiture of our Canadian primary care and licensee business, which significantly improved our balance sheet and eliminated legacy obligations. Following year-end, we also ceased all clinic operations in Mexico after the termination of our agreement with Walmart Mexico. With both legacy business segments now exited, our current focus is on internal restructuring, stabilizing our operations, and preserving cash while evaluating future strategic opportunities. We believe these actions have positioned the Company for a more focused path forward.' Financial Highlights for the fiscal year ended January 31, 2025 For the fiscal year ended January 31, 2025, total consolidated revenues were $19.1 million, consistent with the prior year. Revenues from continuing operations increased 26% to $8.7 million driven by the full-year contribution from MedSpa operations and the continued activity of the Mexico division through fiscal year-end. MedSpa revenues were $1.03 million, up 90% year-over-year. Discontinued operations contributed $10.4 million in revenue prior to the sale of the Canadian medical clinic and licensee business on December 1, 2024. Note on Mexico Operations: The 2025 financial statements reflect the Mexico clinic operations as part of continuing operations, as these locations were active through January 31, 2025. However, subsequent to year-end, all operations in Mexico were fully ceased as of June 30, 2025 following the formal termination of the Company's agreement with Walmart Mexico. As such, the Mexico division is no longer part of Jack Nathan Health's active business going forward. The Company reported a loss from continuing operations of $2.5 million, compared to $1.3 million in the prior year. However, discontinued operations yielded a net gain of $9.99 million, largely driven by a $16.4 million gain on the sale of the Canadian operations. Balance Sheet as of January 31, 2025 Working capital improved to $1.4 million, compared to a working capital deficit of $0.5 million the year prior. Shares Outstanding As of January 31, 2025, the Company had 87,099,159 common shares outstanding, 1,650,000 stock options outstanding and 335,004 DSUs outstanding. For further information regarding the Company's financial results for fiscal year ended January 31, 2025, please refer to the audited annual consolidated financial statements of the Company as at and for the 12 months ended January 31, 2025 together with the corresponding MD&A, available at and the JNH website https// About Jack Nathan Medical Corp. Jack Nathan Health® is a provider of MedSpa services in Canada and a former operator of one of the largest retail medical clinic networks in North America. Established in 2006 the Company expanded its international footprint, delivering exceptional, state-of-the-art, turn-key medical centers in 253 locations globally, with 193 corporately owned and operated. In Canada, the Company grew to 82 locations, including 80 clinics in Walmart locations in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and Quebec and 2 independent locations, with 22 corporate owned and operated clinics of which 3 included Rehab services and 6 included MedSpa services. In Mexico, the Company grew to 171 corporate owned clinics across Mexico within 3 divisions, including 165 retail clinics, 5 clinics inside Walmart Distribution Centers servicing Walmart Associates, and 1 multidisciplinary clinic. In December 2024, Jack Nathan Health restructured its Canadian medical operations through an asset sale to Well Health Technologies Corp. Following the exit from its Walmart Mexico operations in May 2025, the Company continues to operate its Canadian MedSpa clinics and is actively evaluating strategic opportunities for its future business in Canada, Mexico & USA. For more information, visit https// or Neither the TSX Venture Exchange nor its Regulation Services Provider (as defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Appendix: Certain statements contained in this press release constitute 'forward-looking information' as such term is defined in applicable Canadian securities legislation. The words 'may', 'would', 'could', 'should', 'potential', 'will', 'seek', 'intend', 'plan', 'anticipate', 'believe', 'estimate', 'expect' and similar expressions as they relate to Jack Nathan are intended to identify forward- looking information. All statements other than statements of historical fact may be forward- looking information. Such statements reflect the Company's current views and intentions with respect to future events, and current information available to them, and are subject to certain risks, uncertainties, and assumptions Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. Such factors include but are not limited to: changes in economic conditions or financial markets; increases in costs; litigation; legislative and other judicial, regulatory, political, and competitive developments; and operational difficulties. This list is not exhaustive of the factors that may affect forward-looking information. These and other factors should be considered carefully, and readers should not place undue reliance on such forward- looking information. Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward- looking information. The forward-looking information included in this press release is made as of View source version on Jack Nathan Medical Corp., Mike Marchelletta, Chief Executive Officer,(647)-488-5008 KEYWORD: NORTH AMERICA CANADA INDUSTRY KEYWORD: HEALTH HOSPITALS PRACTICE MANAGEMENT OTHER HEALTH MANAGED CARE GENERAL HEALTH SOURCE: Jack Nathan Medical Corp. Copyright Business Wire 2025. PUB: 07/11/2025 08:25 PM/DISC: 07/11/2025 08:25 PM
